Navigation Links
InforMedix Retains Murdock Capital Partners
Date:3/11/2008

rtain your call. By simply identifying yourself as interested in InforMedix, you will be directed to the proper party. Murdock's phone number is 212 421-2545, or you can reach them by e mail at murdockcapital@gmail.com."

About InforMedix

InforMedix, Inc., based in Rockville, Maryland, has developed the Med- eMonitor(TM) System as The Medication Adherence Solution for consumer product and disease management markets, to deliver peace-of-mind, improved independent living, and better health outcomes to patients and their loved ones. The Med- eMonitor System ("Medication, Safe and Easy"(TM)) integrates a portable patient-interactive "smart pillbox", hardware, software, and 24/7 monitoring. This is designed to enable chronically ill patients and their loved ones, professionals in disease management programs, and medical researchers to efficiently monitor and manage Med-eMonitor users' medication and care plan adherence, clinical response, and drug safety. For more information, visit http://www.informedix.com

About Murdock Capital Partners

Murdock Capital Partners, based in New York City, is a private merchant banking firm providing corporate finance and financial advisory services. Murdock Capital acts as financial intermediary and principal for small and medium size companies and provides business counsel on a company's finances, including mergers and acquisitions, public and private financing, management buy-outs and corporate divestitures. Murdock Capital's professionals create significant value for their client companies by acting in a multi faceted capacity as financial partners and strategic advisers. Preferable transactions are $3 million to $50 million; however situations that require up to $200 million for later stage companies are well within Murdock's purview. Acting as principals and working with a substantial number of institutions,
'/>"/>

SOURCE InforMedix Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Autism Consultant Valerie Herskowitz Retains NewsMark Public Relations to Herald the Autism Support Village and Launch of www.valerieherskowitz.com
2. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
3. SpectraScience, Inc. Retains Hayden Communications
4. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
5. Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With Worlds Most Advanced Cardiac Scanner
6. Big A Drug Stores, Inc. Retains DJM Realty to Dispose of All Stores Operating Under the Names of Drug Emporium, Big A, Camelot, Drug Fair and Drug Barn
7. QMed, Inc. Retains Lazard Middle Market
8. The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR
9. Genesis Technology Group Retains CCG Elite
10. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
11. Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2008)...tic children whose parents have high expectations ...kely to have symptoms than other children dealing ...dren also are more likely to use asthma controller...for taking medicine and if their parents clearly u... The study, which appears in the Oct. 2008 issue o...
(Date:10/3/2008)...ding is beneficial. But can it help kids lose weig...terature on obese adolescents, researchers at Duke...ight type of novel may make a difference. , The ...who were already in a comprehensive weight loss pr... Rescue (Beacon Street Press). It was carefully cr...
(Date:10/3/2008)... Inc. Magazine recently included,Connolly Consulti...ng,private companies in the country. The list is t...egment of the economy -- America,s,independent-min...es,represent the backbone of the U.S. economy., (...3/NY36880LOGO ), Connolly Consulting,s consisten...
(Date:10/3/2008)...idents to Eat Right, Move More and ...t. 3 /PRNewswire/ -- The last decade can be define...hich seem to go in and out,of fashion like shoulde...en,slim. Two out of three Americans -- including 2...weight or obese., A new campaign crossing the cou...
Breaking Medicine News(10 mins):Health News:Children's asthma affected by parental expectations 2Health News:Duke researchers show reading can help obese kids lose weight 2Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3
...unction is associated with loss of libido, low mot... who have attained their menopause or whose ovarie...ydroepiandosterone(DHEA), may serve as an effectiv...according to a study released at the 96th annual m...
...h Israel Deaconess Medical Center reported in the ...perimental Gene Therapy method has safely introduc...a. This method shows signs of helping these men f... protein they lack. None of the patients suffers ...
...ip seems to be the latest mantra of Pfizer. The p...ply free antifungal drug to 50 countries hardest h...omes close on the heels of the South African Gover...cal companies. In an announcement on Wednesday Pf...
...napat Rao Matapurkar, from Maulana Azad Medical Co...inning the first patent on organ regeneration from...uccessfully regenerating / repairing organs in hum... patent office granted him a patent on this techni...
Other Medicine News:
(Date:10/6/2008)...se 3b Studies with Durezol Dosed Prior to Surgery,...peutics, Inc., a,privately held ophthalmic-focused...urezol(TM) (difluprednate ophthalmic emulsion) 0.0...as approved by the U.S. Food and,Drug Administrati...eroid,indicated for the treatment of inflammation ...
(Date:10/6/2008)...lif. and SEATTLE, Oct. 6 /- Complete,...human genome sequencing,company, and the Institute...artnership to conduct populationwide human genome ...enomics will use its proprietary,DNA sequencing te...vided by,ISB. Then, once proof-of-concept has been...
(Date:10/6/2008)...netic Characteristics of Naltrexone SR Associated ...l Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCall... a biopharmaceutical company focused on the treatm...lated disorders, today presented,data showing the ...,bupropion SR), successfully achieved key objectiv...
(Date:10/6/2008)...Other Product - Company,s Bioabsorbable Stent - Al...G, Oct. 6 /- Data from multiple clini... OrbusNeich,s Genous Bio-engineered R,stent, will ...vascular,Therapeutics symposium, TCT 2008, in Wash...the Academic Medical Center in,Amsterdam will prov...
Breaking Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 1Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 8Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 1Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 2Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 3Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 1Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 2Food for thought 2735 2/ 1
... Jun 09, 2007 (MARKET WIRE via COMTEX News Network...sidiary of Endo,Pharmaceuticals Holdings Inc. (NAS... randomized, double-blind, placebo-controlled,clin...e) 2.5 mg,tablets as a six-day preventative treatm...raine (MM). The data demonstrated,that FROVA signi...
...., June 11, 2007--New research supported by the,...of Arthritis and,Musculoskeletal and Skin Diseas...ion gabapentin , which is used for certain,type...he pain and,other symptoms associated with the c..., fibromyalgia. , In the NIAMS-sponsored, random...
Other Medicine Technology:Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7Gabapentin Shown Effective for Fibromyalgia Pain 2Gabapentin Shown Effective for Fibromyalgia Pain 3
BiodivYsio stent with biocompatible coating (phosphorylcholine)
The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, s
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support.
Medicine Products: